Sylvie Kossodo

Summary

Publications

  1. ncbi Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis
    Jeffrey D Peterson
    VisEn Medical Inc, 45 Wiggins Avenue, Bedford, MA 01730, USA
    Arthritis Res Ther 12:R105. 2010
  2. ncbi Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT)
    Sylvie Kossodo
    VisEn Medical, Bedford, MA, USA
    Mol Imaging Biol 12:488-99. 2010
  3. ncbi Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model
    Maritza A Middelkamp-Hup
    Wellman Laboratories of Photomedicine, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    J Invest Dermatol 121:634-9. 2003

Research Grants

  1. Development of MMP-13 Molecular Imaging Probes
    Sylvie Kossodo; Fiscal Year: 2003
  2. Fluorescence Endoscopy for Enhanced Adenoma Detection
    Sylvie Kossodo; Fiscal Year: 2005

Collaborators

Detail Information

Publications3

  1. ncbi Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis
    Jeffrey D Peterson
    VisEn Medical Inc, 45 Wiggins Avenue, Bedford, MA 01730, USA
    Arthritis Res Ther 12:R105. 2010
    ....
  2. ncbi Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT)
    Sylvie Kossodo
    VisEn Medical, Bedford, MA, USA
    Mol Imaging Biol 12:488-99. 2010
    ..We developed a novel near-infrared-labeled optical agent for the in vivo detection and quantification of α(v)β(3)/α(v)β(5)...
  3. ncbi Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model
    Maritza A Middelkamp-Hup
    Wellman Laboratories of Photomedicine, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    J Invest Dermatol 121:634-9. 2003
    ..Based on these results, we conclude that PDT-BPD can lead to selective eradication of these tumors. Further studies investigating the efficacy of PDT-BPD for human hemangiomas are warranted...

Research Grants2

  1. Development of MMP-13 Molecular Imaging Probes
    Sylvie Kossodo; Fiscal Year: 2003
    ..Thus, the specific aims of this proposal represent the first steps towards the development of a clinical agent to image molecular profiles of cancer in vivo. ..
  2. Fluorescence Endoscopy for Enhanced Adenoma Detection
    Sylvie Kossodo; Fiscal Year: 2005
    ..e., NIRF endoscopy) that is directly applicable to the clinic, and (3) with clinically viable sensitivity and specificity. ..